跳至主要内容
临床试验/NCT06237556
NCT06237556招募中不适用

The Effect of Melatonin on Anxiety and Sleep Quality in the Peri-Operative Course of Adults Undergoing Coronary Artery Bypass Graft Surgery: Prospective Randomized Controlled Study

Ain Shams University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Quality of sleep

研究概览

简要总结

The objective of this study is to evaluate the effect of melatonin on post operative sleeping quality, anxiety, and post-operative opioid requirements in adults post coronary artery bypass graft (CABG) surgery.

详细描述

Sleep disturbance is common among patients undergoing coronary artery bypass graft (CABG), especially during the first week of the postoperative period. Sleep disorders result in important impacts on morbidity, mortality, and quality of life.

Many factors are thought to be the cause of sleep disturbance in patients who have undergone CABG. These factors include environmental stimuli (e.g. noise and uncomfortable beds), individual characteristics (e.g. primary sleep disorder and comorbid health), nature of cardiac illnesses, and surgical complications (e.g. incisional pain, use of diuretics and resultant nocturia, dyspnea, and difficulty in finding the proper position to sleep).

Furthermore, decreased plasma melatonin concentrations have been documented during surgery and the postsurgical period in patients having undergone CABG.

Melatonin is a neurohormone originating from the amino acid, tryptophan, and is mainly secreted by the pineal gland into the blood stream and the cerebrospinal fluid. It possesses a circadian secretion pattern with a low blood concentration during the day and a high concentration at night.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 40-60 years.
  • Both sexes.
  • Patients undergoing standard on-pump CABG with the same technique by the same surgical team.

排除标准

  • Refusal of procedure or participation in the study by patients.
  • Patients with known history of allergy to one of study drugs
  • Patients taking psychiatric medications, CNS depressants, and hypnotic drugs.
  • Patients with neurological disorders stroke, intracranial hemorrhage and surgery.
  • Patients with a history of suffering from any sleep disorder.
  • Severe circulatory or respiratory disease.
  • Patients with obstructive sleep apnea.
  • Cognitive or psychiatric illness that leads to inability to cooperate, speak or provide informed consent

研究组 & 干预措施

Control group

Placebo Comparator

Patients in the control group will receive placebo.

干预措施: Placebo (Other)

Melatonin group

Experimental

Three days before the operation patients will receive 5 mg of melatonin (Melatonin, Nature Made, Canada, and USA) one hour before assigned sleep time until the time of discharge from hospital.

干预措施: Melatonin 5 MG (Drug)

结局指标

主要结局

Quality of sleep

时间窗: Five days postoperative

Sleep quality will be evaluated using the Groningen Sleep Quality Score (GSQS), The GSQS consists of 15 questions about the previous night's sleep, answered with Yes or No.

次要结局

  • Anxiety(24 hours postoperative)
  • The degree of pain(24 hours postoperative)
  • Opioid requirements(24 hours postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed ashraf abdelaziz bayoumi

Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Ain Shams University, Egypt.

Ain Shams University

研究点 (1)

Loading locations...

相似试验